Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3506951018 | Cilastatin sodium (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3506952013 | Cilastatin sodium | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cilastatin sodium | Is a | Cilastatin | false | Inferred relationship | Some | ||
| Cilastatin sodium | Has disposition | Peptide hydrolase inhibitor | true | Inferred relationship | Some | ||
| Cilastatin sodium | Is a | Peptide hydrolase inhibitor | true | Inferred relationship | Some | ||
| Cilastatin sodium | Is modification of | Cilastatin | true | Inferred relationship | Some | ||
| Cilastatin sodium | Is a | Organic sulfide compound | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem anhydrous (as imipenem) 500 mg powder for solution for injection vial | Has precise active ingredient | True | Cilastatin sodium | Inferred relationship | Some | 2 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial | Has precise active ingredient | True | Cilastatin sodium | Inferred relationship | Some | 2 |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg powder for suspension for injection vial | Has precise active ingredient | True | Cilastatin sodium | Inferred relationship | Some | 2 |
| Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has precise active ingredient | False | Cilastatin sodium | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR